Voucher-Based Incentives in a Prevention Setting (VIPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00607269|
Recruitment Status : Completed
First Posted : February 5, 2008
Results First Posted : August 1, 2013
Last Update Posted : August 1, 2013
|Condition or disease||Intervention/treatment||Phase|
|Substance-related Disorders||Behavioral: Voucher-Based Reinforcement Therapy||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||131 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Voucher-Based Incentives in a Prevention Setting|
|Study Start Date :||April 2005|
|Actual Primary Completion Date :||February 2008|
|Actual Study Completion Date :||February 2008|
No Intervention: Control
Control condition receiving minimal incentives for service program attendance and participation.
Experimental: Contingency Management
Contingency management (Voucher-Based Reinforcement Therapy) intervention providing positive reinforcement for service program participation and attendance, enactment of prosocial/health behavior, and/or clean urine samples (i.e., no illicit drug use) and clean breathalyzer tests (i.e., BA < 0.05).
Behavioral: Voucher-Based Reinforcement Therapy
Participants were randomized into either the CM or control condition. Both conditions earned points for attendance and participation (max 364 points).
Participants in the CM condition also earned points for targeted health-promoting behaviors and for drug/alcohol abstinence. CM points for targeted health-promoting behaviors were not limited. Points for abstaining from substance use were awarded based on a Level 1 (recent abstinence for amphetamine, methamphetamine, PCP, and cocaine metabolites, as well as blood alcohol <0.05) urine sample.
Other Name: VIPS
- Amount ($) Earned for Targeted Prosocial and Healthy Behaviors [ Time Frame: 24 Weeks ]Participants earned contingency management vouchers for targeted prosocial and healthy behaviors. 1 voucher = $1
- Proportion of Level 1 (i.e., Drug Negative Urines and Alcohol Negative Breath) Clean Urine Samples Provided at 12-month Follow-up, by Condition. [ Time Frame: 24 Weeks ]
- Self-reported Psychiatric Symptoms at 12-month Follow-up. [ Time Frame: 12 months ]As measured by the General Severity Index (GSI), a summary domain included on the Brief Symptom Inventory. The GSI combines information on both the number of symptoms described and the severity of those symptoms. Lower values on the GSI indicate less severe symptoms. Normative non-patient populations have been shown to have average GSI scores with a mean of 0.30 and a standard deviation of 0.31. Normative outpatient psychiatric patients have demonstrated GSI scores with a mean of 1.32 with a standard deviation of 0.72.
- Self-reported Sexual Behaviors at 12-month Follow-up [ Time Frame: 12 months ]Count of recent (past 30 days) male sexual partners.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00607269
|United States, California|
|Friends Community Center|
|Los Angeles, California, United States, 90028|
|Principal Investigator:||Cathy J Reback, Ph.D.||Friends Research Institute, Inc.|
|Study Director:||Jesse B Fletcher, Ph.D.||Friends Research Institute, Inc.|